Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-24-129070

Director acquired 30,110 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Redmile Group, LLC Director 2024-12-12 Conversion +30,110 12,827,946 I
Derivatives
Redmile Group, LLC Director 2024-12-12 Conversion · Class A Convertible Preferred Stock −6,022 2,755,086 I
Loading xslF345X05/tm2431235-1_4seq1.xml…